MSD enters licensing pact with five Indian generic firms to manufacture, distribute COVID-19 antiviral drug molnupiravir

Under the agreements, MSD will provide licences to these manufacturers to supply molnupiravir to India and more than 100 LMICs. MSD is also in discussions with the Medicines Patent Pool to explore the potential for additional licences.

from Moneycontrol Business News https://ift.tt/2S1U12h